Immunological methods and compositions for the treatment of...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/00 (2006.01) A61K 38/00 (2006.01) A61K 38/03 (2006.01) A61K 39/00 (2006.01) C07K 14/47 (2006.01)

Patent

CA 2481952

The present invention relates to immunogenic compositions and peptides comprising residues 4-10 (FRHDSGY) of the amyloid peptide Abeta42. The invention further relates to antibodies that bind to the Abeta(4-10) antigenic determinant. The invention provides methods for treating Alzheimer's disease and for reducing the amyloid load in Alzheimers patients. The invention also relates to methods for designing small molecule inhibitors of amyloid deposition.

La présente invention concerne des compositions immunogènes et des peptides comprenant des résidus 4-10 (FRHDSGY) du peptide amyloïde Abeta¿42?. L'invention concerne également des anticorps qui se fixent au déterminant antigénique d'Abeta ¿(4-10)?. L'invention concerne des méthodes de traitement de la maladie d'Alzheimer et de réduction de la charge amyloïde chez des patients atteints de la maladie d'Alzheimer. L'invention concerne des méthodes de conception de petites molécules inhibitrices de dépôt amyloïde.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunological methods and compositions for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunological methods and compositions for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunological methods and compositions for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1635350

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.